Vantage Health lowers exercise price of warrants to $0.05 from $3.00

Company encourages holders to exercise warrants to generate funds

By Devika Patel

Knoxville, Tenn., Aug. 5 - Vantage Health revised the price of warrants it sold in a June 30, 2010 private placement, according to an 8-K filed Friday with the Securities and Exchange Commission.

The warrants, for 7,859,375 common shares, originally had a strike price of $3.00.

On Aug. 4, the company's board of directors passed a resolution to reduce the strike price of the warrants to $0.05 per share, effective immediately, in order to encourage the warrant holders to exercise their warrants and generate $392,269 of working capital.

The company will use these proceeds to implement its business plan.

Vantage Health is a pharmaceutical company based in Los Angeles.

© 2015 Prospect News.
All content on this website is protected by copyright law in the U.S. and elsewhere. For the use of the person downloading only.
Redistribution and copying are prohibited by law without written permission in advance from Prospect News.
Redistribution or copying includes e-mailing, printing multiple copies or any other form of reproduction.